TRINSEO PLC (TSE)

IE0000QBK8U7 - Common Stock

4.77  -0.35 (-6.84%)

After market: 5.02 +0.25 (+5.24%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to TSE. TSE was compared to 83 industry peers in the Chemicals industry. Both the profitability and financial health of TSE have multiple concerns. TSE does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

TSE had negative earnings in the past year.
In the past year TSE has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: TSE reported negative net income in multiple years.
TSE had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

TSE has a Return On Assets of -17.19%. This is amonst the worse of the industry: TSE underperforms 87.95% of its industry peers.
Industry RankSector Rank
ROA -17.19%
ROE N/A
ROIC N/A
ROA(3y)-8.42%
ROA(5y)-4.33%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

TSE's Gross Margin of 6.51% is on the low side compared to the rest of the industry. TSE is outperformed by 87.95% of its industry peers.
TSE's Gross Margin has declined in the last couple of years.
TSE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-30.83%
GM growth 5Y-19.48%

1

2. Health

2.1 Basic Checks

TSE does not have a ROIC to compare to the WACC, probably because it is not profitable.
TSE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, TSE has less shares outstanding
Compared to 1 year ago, TSE has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.00, we must say that TSE is in the distress zone and has some risk of bankruptcy.
TSE's Altman-Z score of 1.00 is on the low side compared to the rest of the industry. TSE is outperformed by 77.11% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1
ROIC/WACCN/A
WACC6.43%

2.3 Liquidity

TSE has a Current Ratio of 1.38. This is a normal value and indicates that TSE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.38, TSE is doing worse than 78.31% of the companies in the same industry.
A Quick Ratio of 0.84 indicates that TSE may have some problems paying its short term obligations.
With a Quick ratio value of 0.84, TSE is not doing good in the industry: 78.31% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.84

3

3. Growth

3.1 Past

The earnings per share for TSE have decreased strongly by -41.02% in the last year.
The Revenue has decreased by -7.45% in the past year.
The Revenue has been decreasing by -4.48% on average over the past years.
EPS 1Y (TTM)-41.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-57.28%
Revenue 1Y (TTM)-7.45%
Revenue growth 3Y10.22%
Revenue growth 5Y-4.48%
Sales Q2Q%-1.29%

3.2 Future

The Earnings Per Share is expected to grow by 29.52% on average over the next years. This is a very strong growth
Based on estimates for the next years, TSE will show a small growth in Revenue. The Revenue will grow by 1.70% on average per year.
EPS Next Y-1.44%
EPS Next 2Y22.04%
EPS Next 3Y21.5%
EPS Next 5Y29.52%
Revenue Next Year-3.77%
Revenue Next 2Y-0.11%
Revenue Next 3Y1.7%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

TSE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TSE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TSE indicates a slightly more expensive valuation: TSE is more expensive than 61.45% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.14

4.3 Compensation for Growth

A more expensive valuation may be justified as TSE's earnings are expected to grow with 21.50% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.04%
EPS Next 3Y21.5%

1

5. Dividend

5.1 Amount

With a yearly dividend of 0.78%, TSE is not a good candidate for dividend investing.
TSE's Dividend Yield is slightly below the industry average, which is at 3.28.
Compared to an average S&P500 Dividend Yield of 2.34, TSE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.78%

5.2 History

The dividend of TSE decreases each year by -20.01%.
TSE has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-20.01%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

TSE has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-0.32%
EPS Next 2Y22.04%
EPS Next 3Y21.5%

TRINSEO PLC

NYSE:TSE (12/20/2024, 8:04:00 PM)

After market: 5.02 +0.25 (+5.24%)

4.77

-0.35 (-6.84%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)N/A N/A
Inst Owners72.37%
Inst Owner Change-6.51%
Ins Owners4.94%
Ins Owner Change4.12%
Market Cap168.86M
Analysts70
Price Target5.53 (15.93%)
Short Float %4.28%
Short Ratio3.62
Dividend
Industry RankSector Rank
Dividend Yield 0.78%
Dividend Growth(5Y)-20.01%
DP-0.32%
Div Incr Years0
Div Non Decr Years0
Ex-Date01-09 2025-01-09 (0.01)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.26%
Min EPS beat(2)-15.41%
Max EPS beat(2)-9.11%
EPS beat(4)1
Avg EPS beat(4)-36.07%
Min EPS beat(4)-122.75%
Max EPS beat(4)2.99%
EPS beat(8)1
Avg EPS beat(8)-74.84%
EPS beat(12)2
Avg EPS beat(12)-54.05%
EPS beat(16)5
Avg EPS beat(16)-37.92%
Revenue beat(2)0
Avg Revenue beat(2)-3.48%
Min Revenue beat(2)-3.76%
Max Revenue beat(2)-3.2%
Revenue beat(4)1
Avg Revenue beat(4)-1.33%
Min Revenue beat(4)-3.76%
Max Revenue beat(4)4.44%
Revenue beat(8)1
Avg Revenue beat(8)-5.97%
Revenue beat(12)2
Avg Revenue beat(12)-4.67%
Revenue beat(16)4
Avg Revenue beat(16)-3.67%
PT rev (1m)-2.98%
PT rev (3m)11.11%
EPS NQ rev (1m)1.16%
EPS NQ rev (3m)-62.63%
EPS NY rev (1m)-3.52%
EPS NY rev (3m)-4.57%
Revenue NQ rev (1m)-1.8%
Revenue NQ rev (3m)-4.38%
Revenue NY rev (1m)-0.67%
Revenue NY rev (3m)-0.75%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 14.14
EPS(TTM)-8.01
EYN/A
EPS(NY)-3.55
Fwd EYN/A
FCF(TTM)-4.08
FCFYN/A
OCF(TTM)-2.31
OCFYN/A
SpS99.69
BVpS-13.56
TBVpS-33.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.19%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.51%
FCFM N/A
ROA(3y)-8.42%
ROA(5y)-4.33%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-30.83%
GM growth 5Y-19.48%
F-Score4
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 12.87
Cap/Depr 29.24%
Cap/Sales 1.78%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.38
Quick Ratio 0.84
Altman-Z 1
F-Score4
WACC6.43%
ROIC/WACCN/A
Cap/Depr(3y)54.78%
Cap/Depr(5y)61.31%
Cap/Sales(3y)2.44%
Cap/Sales(5y)2.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-41.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-57.28%
EPS Next Y-1.44%
EPS Next 2Y22.04%
EPS Next 3Y21.5%
EPS Next 5Y29.52%
Revenue 1Y (TTM)-7.45%
Revenue growth 3Y10.22%
Revenue growth 5Y-4.48%
Sales Q2Q%-1.29%
Revenue Next Year-3.77%
Revenue Next 2Y-0.11%
Revenue Next 3Y1.7%
Revenue Next 5YN/A
EBIT growth 1Y73.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year656.87%
EBIT Next 3Y126.14%
EBIT Next 5YN/A
FCF growth 1Y-287.91%
FCF growth 3Y-23.01%
FCF growth 5Y-20.26%
OCF growth 1Y-136.53%
OCF growth 3Y-16.5%
OCF growth 5Y-16.51%